Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data
SGLT2i and GLP-1 RAs are associated with a reduced risk of incident pneumonia and severe sepsis in patients with T2D. Further research and focused randomised controlled trials are warranted to explore the broader clinical implications of these treatments.
Authors
- David R. J. Riley (ORCID: https://orcid.org/0000-0002-0905-6524)
- Gema Hernández (ORCID: https://orcid.org/0000-0003-4832-455X)
- Uazman Alam (ORCID: https://orcid.org/0000-0002-3190-1122)
- Freddy Frost (ORCID: https://orcid.org/0000-0002-3902-6502)
- Theresa Hydes (ORCID: https://orcid.org/0000-0002-7768-6886)
- Alex E. Henney (ORCID: https://orcid.org/0000-0002-8066-9470)
- Daniel James Cuthbertson (ORCID: https://orcid.org/0000-0002-6128-0822)
- Matthew Anson (ORCID: https://orcid.org/0000-0001-9991-7369)
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Liverpool Heart and Chest Hospital (GB)
- TriNetX (United States) (US)
Publication Details
- Journal
- Thorax
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1136/thorax-2024-221906
- Citations
- 17
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.08